Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study.

Dermatology and therapy

Glucagon-like peptide-1 receptor agonist, semaglutide, attenuates intravenous self-administration of fentanyl in female rats.

bioRxiv : the preprint server for biology

Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis.

Indian journal of endocrinology and metabolism

Impact of GLP-1 Receptor Agonists on Chronic Low Back Pain in Patients with Obesity: A Prospective Pilot Cohort Study.

medRxiv : the preprint server for health sciences

Semaglutide in Metabolic Medicine: A Review on Clinical Applications and Emerging Therapeutics.

Saudi medical journal

Real-world use of submaximal doses of long-acting GLP-1 receptor agonist semaglutide in patients with obesity: a prospective observational study.

Scientific reports

Implementation of the IWQOL-Lite-CT in Observational Research: Comparison of Baseline Scores With a Clinical Trial Population and Psychometric Evaluation.

Clinical obesity

Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis.

Journal of the American College of Cardiology

🚨 For those interested in PEPTIDES please read up: My goal is to TRAIN and EDUCATE as many medical professionals about the proper use of peptides over the next 5 years. I’m working behind the scenes on the legal and FDA-related availability but IMO that’s an inevitability. https://t.co/uo0l4QBLg9

Reptides currently has 47 peptides ranked from S-F S tier: Tirzepatide Semaglutide Retatrutide Liraglutide Tesamorelin HGH HCG GHK-Cu A tier: SS-31 PT-141 Sermorelin BPC-157 TB-500 CJC+Ipa blend CJC-1295 Ipamorelin BPC+TB blend Melanotan II KLOW GLOW B tier: Cagrisema

India’s GLP-1 market has exploded from ₹121 crore to ₹1,736 crore in four years. After semaglutide’s patent expiry on 20 March, 13 companies launched 26 brands within a week. Prices crashed from nearly ₹16,000 per month to as low as ₹1,290, with Glenmark pricing a weekly

$HIMS was sitting near $15 just a few months ago with sentiment at absolute lows. This is exactly where long-term conviction matters. The people who stuck with $HIMS through peak fear are already sitting on an 80%+ move, and I still think this is just the beginning. Remember,

The peptides with the most human clinical data, listed. Not results. Not anecdotes. Strictly human trial evidence. 1.Semaglutide (the “OG” GLP-1) GLP-1 receptor agonist. Quiets food noise, slows gastric emptying, drives significant weight loss. 2.Tirzepatide (the upgrade)

Most people still don't know there's an FDA approved GLP-1 pill for weight loss that requires no injection and no fasting, and the ones who do know are ignoring it for one reason, Because it's not a peptide. Foundayo, the brand name for orforglipron, was approved by the FDA in

Tadalafil users Airlines lost my bag, inside were my a few of my daily stack including; Tadalafil, Semaglutide & Tirzepatide, BPC-157, Thymosin Beta-4, CJC-1295 & Ipamorelin, Epithalon, GHK-Cu, Semax & Selank and DSIP. Luckily I still have most of my others. What do I do?

1/ The word “peptide” has become almost meaningless on social media. Some peptides have decades of human data, known receptors, and FDA approval. Others are supported primarily by animal studies, mechanistic theories, and anecdotes. The most important takeaway from Dr. Abud https://t.co/VlySymIWg7